Latest revenue
$913
as of 2021-09-30
Latest net income
$-27.2K
as of 2021-09-30
Net margin
-2980.4%
as of 2021-09-30
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $4.0M
- Enterprise value
- $4.0M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $0.04
- 52-wk low
- $0.00
- Beta
- —
- Shares out
- 977.0M
5-year trend
What this company does
Item 1. Business. As used in this Report, all references to “we,” “our” and “us” for periods prior to the closing of the Share Exchange refer to Dror Ortho-Design Ltd., a company incorporated under the laws of the State of Israel, and for periods subsequent to the closing of the Share Exchange refer to Dror Ortho-Design, Inc., a Delaware corporation and its direct and indirect subsidiaries. Overview We were incorporated as Novint Technologies, Inc. in the State of New Mexico in April 1999. On February 26, 2002, we changed our state of incorporation to Delaware by merging with Novint Technologies, Inc., a Delaware corporation. On July 5, 2023, we entered into a share exchange agreement with…
AI summary unavailable — showing raw filing excerpt
Generated from DROR's filing dated 2026-02-27
Key risks
Item 1A. Risk Factors. Our business and an investment in our securities are subject to a variety of risks. The following risk factors describe the most significant events, facts or circumstances that we believe could have a material adverse effect upon our business, financial condition, results of operations, ability to implement our business plan, and the price at which our Common Stock is quoted on the OTC Pink Market. Many of these events are outside of our control. The risks described below are not the only ones facing our Company. Additional risks not presently known to us or that we currently believe are immaterial may also impair our business operations. If any of these risks…
AI summary unavailable — showing raw filing excerpt
Generated from DROR's filing dated 2026-02-27
Profitability
Operating margin
-6631.7%
Net margin
-6639.8%
Return on equity
88.6%
94.4%Return on assets
-982.8%
12.8%Leverage
Debt / equity
-1.09×
61.1%Debt / assets
1209.8%
677.9%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | — | — | $-638.7K | -10.9% | — |
Q4 2025 2025-12-31 | — | — | $-555.9K | +51.0% | — |
Q3 2025 2025-09-30 | — | — | $-653.5K | +64.2% | — |
Q2 2025 2025-06-30 | — | — | $-759.3K | +49.6% | — |
Q1 2025 2025-03-31 | — | — | $-576.1K | +56.0% | — |
Q4 2024 2024-12-31 | — | — | $-1.1M | — | — |
Q3 2024 2024-09-30 | — | — | $-1.8M | -230.0% | — |
Q2 2024 2024-06-30 | — | — | $-1.5M | -1754.2% | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Dental Equipment & Supplies · SIC 3843
Your notes
Keep private notes on DROR — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for DROR in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns DROR
No institutional holdings on file for DROR yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once DROR's latest filing finishes processing.